Drexel Morgan & Co.’s Johnson & Johnson Position
Does Drexel Morgan & Co. own Johnson & Johnson (JNJ)? Yes — 216.2K shares worth $53M (+7.75% of its 13F portfolio) as of Q1 2026.
Position Value
$53M
Q1 2026
Shares
216.2K
% of Portfolio
+7.75%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 216.2K | $53M | +7.75% |
| Q4 2025 | 216.2K | $45M | +7.00% |
| Q3 2025 | 216.2K | $40M | +6.30% |
| Q2 2025 | 216.3K | $33M | +5.87% |
| Q1 2025 | 216.3K | $36M | +7.53% |
| Q4 2024 | 216.3K | $31M | +6.45% |
| Q3 2024 | 216.3K | $35M | +6.51% |
| Q2 2024 | 216.3K | $32M | +6.78% |
| Q1 2024 | 216.3K | $34M | +7.04% |
| Q4 2023 | 216.1K | $34M | +7.83% |
| Q3 2023 | 216.0K | $34M | +9.15% |
| Q2 2023 | 215.7K | $36M | +9.26% |
| Q1 2023 | 215.7K | $33M | +8.43% |
| Q4 2022 | 215.7K | $38M | +7.83% |
| Q3 2022 | 215.7K | $35M | +8.46% |
| Q2 2022 | 215.4K | $38M | +10.51% |
| Q1 2022 | 215.4K | $38M | +11.10% |
| Q4 2021 | 215.4K | $37M | +10.66% |
| Q3 2021 | 215.4K | $35M | +11.18% |
| Q2 2021 | 217.2K | $36M | +10.56% |
| Q1 2021 | 220.1K | $36M | +9.17% |
| Q4 2020 | 220.1K | $35M | +9.47% |
| Q3 2020 | 120.1K | $18M | +6.29% |
| Q2 2020 | 119.8K | $17M | +6.37% |
| Q1 2020 | 119.6K | $16M | +6.08% |
| Q4 2019 | 20.9K | $3M | +2.29% |
| Q3 2019 | 19.6K | $3M | +1.96% |
| Q2 2019 | 20.0K | $3M | +2.15% |
| Q1 2019 | 19.9K | $3M | +2.47% |
| Q4 2018 | 19.7K | $3M | +2.54% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Drexel Morgan & Co.’s full portfolio or all institutional holders of JNJ.